Efficacy of combined ruxolitinib and decitabine in patients with accelerated and blast-phase myeloproliferative neoplasms: Results of a phase II study (MPN-RC109 trial) Meeting Abstract
| Authors: | Rampal, R. K.; Mascarenhas, J.; Kosiorek, H. E.; Bhave, R.; Hexner, E. O.; Wang, E. S.; Gerds, A. T.; Heaney, M. L.; Abboud, C. N.; Kremyanskaya, M.; Berenzon, D.; Odenike, O.; Virtgaym, E.; Sandy, L.; Weinberg, R. S.; Najfeld, V.; Salama, M. E.; Levine, R. L.; Mesa, R. A.; Dueck, A. C.; Hoffman, R. |
| Abstract Title: | Efficacy of combined ruxolitinib and decitabine in patients with accelerated and blast-phase myeloproliferative neoplasms: Results of a phase II study (MPN-RC109 trial) |
| Meeting Title: | 60th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 132 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Dec 1-4 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2018-11-29 |
| Language: | English |
| ACCESSION: | WOS:000454842800198 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood-2018-99-111935 |
| Notes: | Meeting Abstract: 3027 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work